Y. Şenol Et Al. , "Pharmacometabolomic assessment of vitamin E loaded human serum albumin nanoparticles on HepG2 cancer cell lines," Journal of Drug Delivery Science and Technology , vol.79, 2023
Şenol, Y. Et Al. 2023. Pharmacometabolomic assessment of vitamin E loaded human serum albumin nanoparticles on HepG2 cancer cell lines. Journal of Drug Delivery Science and Technology , vol.79 .
Şenol, Y., KAPLAN, O., VARAN, C., Demirtürk, N., Öncül, S., Fidan, B. B., ... ERCAN, A.(2023). Pharmacometabolomic assessment of vitamin E loaded human serum albumin nanoparticles on HepG2 cancer cell lines. Journal of Drug Delivery Science and Technology , vol.79.
Şenol, Yasin Et Al. "Pharmacometabolomic assessment of vitamin E loaded human serum albumin nanoparticles on HepG2 cancer cell lines," Journal of Drug Delivery Science and Technology , vol.79, 2023
Şenol, Yasin Et Al. "Pharmacometabolomic assessment of vitamin E loaded human serum albumin nanoparticles on HepG2 cancer cell lines." Journal of Drug Delivery Science and Technology , vol.79, 2023
Şenol, Y. Et Al. (2023) . "Pharmacometabolomic assessment of vitamin E loaded human serum albumin nanoparticles on HepG2 cancer cell lines." Journal of Drug Delivery Science and Technology , vol.79.
@article{article, author={Yasin Şenol Et Al. }, title={Pharmacometabolomic assessment of vitamin E loaded human serum albumin nanoparticles on HepG2 cancer cell lines}, journal={Journal of Drug Delivery Science and Technology}, year=2023}